OSEL DEVICES LIMITED Stock Price Today (NSE: OSELDEVICE)
Fundamental Score
OSEL DEVICES LIMITED Share Price — Live NSE/BSE Price, Fundamentals & Analysis
OSEL DEVICES LIMITED share price today is ₹413.05, down 2.14% on NSE/BSE as of 31 July 2026. OSEL DEVICES LIMITED (OSELDEVICE) is a Small-cap company in the Medical Equipment & Supplies sector with a market capitalisation of ₹782.87 (Cr). The 52-week high for OSELDEVICE share price is ₹824.00 and the 52-week low is ₹390.00. At a P/E ratio of 26.76x, OSELDEVICE is currently trading below its industry average P/E of 36.70x. The company has a Return on Equity (ROE) of 19.56% and a debt-to-equity ratio of 0.49.
OSEL DEVICES LIMITED Share Price Chart — NSE/BSE Historical Performance
OSEL DEVICES LIMITED share price chart: -14.59% return over the past month. 52-week high ₹824.00, 52-week low ₹390.00.
OSEL DEVICES LIMITED — Last 10 Trading Days
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| ₹427.90 | ₹428.00 | ₹405.00 | ₹413.05 | 11.80K (Cr) | |
| ₹426.80 | ₹426.80 | ₹411.20 | ₹422.10 | 9.20K (Cr) | |
| ₹411.70 | ₹415.05 | ₹390.00 | ₹413.55 | 33.20K (Cr) | |
| ₹415.00 | ₹421.90 | ₹408.00 | ₹409.90 | 15.80K (Cr) | |
| ₹429.25 | ₹432.60 | ₹428.00 | ₹430.80 | 7.60K (Cr) | |
| ₹440.00 | ₹449.25 | ₹426.00 | ₹436.65 | 32.80K (Cr) | |
| ₹444.00 | ₹448.80 | ₹441.05 | ₹444.00 | 6.80K (Cr) | |
| ₹452.00 | ₹455.00 | ₹440.00 | ₹442.95 | 12.00K (Cr) | |
| ₹443.05 | ₹451.00 | ₹437.35 | ₹439.95 | 14.60K (Cr) | |
| ₹490.85 | ₹490.85 | ₹475.00 | ₹483.35 | 16.20K (Cr) |
OSEL DEVICES LIMITED — Last 12 Months Price History
| Month | Open | High | Low | Close | Change |
|---|---|---|---|---|---|
| ₹464.00 | ₹490.85 | ₹390.00 | ₹413.05 | -10.98% | |
| ₹464.10 | ₹473.25 | ₹450.00 | ₹471.70 | +1.64% | |
| ₹569.60 | ₹578.45 | ₹495.00 | ₹496.70 | -12.80% | |
| ₹504.95 | ₹614.20 | ₹504.95 | ₹587.35 | +16.32% | |
| ₹510.00 | ₹538.95 | ₹496.35 | ₹523.40 | +2.63% | |
| ₹459.00 | ₹538.00 | ₹444.50 | ₹499.50 | +8.82% | |
| ₹540.00 | ₹567.00 | ₹440.10 | ₹448.25 | -16.99% | |
| ₹762.00 | ₹768.00 | ₹505.80 | ₹555.20 | -27.14% | |
| ₹661.35 | ₹824.00 | ₹616.50 | ₹774.65 | +17.13% |
AI Research Briefing
Powered by Gemini · 2026-04-10
OSEL is betting on inorganic growth in hearing aids, but small-cap liquidity and execution risks loom large.
WHAT'S HAPPENING NOW (last 2-4 weeks)
OSEL Devices secured FDA registration for its Greater Noida hearing aid facility. This unlocks access to the US market, with potential for revenue and margin expansion. Osel also entered an agreement to acquire 90.69% of SFL Hearing Solutions for million.
CORE STORY (THE REAL GAME)
OSEL is trying to become a major hearing aid player, using acquisitions and regulatory approvals to access larger markets and expand its product line. It's an inorganic growth story in a sector ripe for consolidation.
- FDA approval unlocks US market
- Acquisition of SFL Hearing Solutions for ₹300 million
- Medical equipment sector growth at 8.30% CAGR
- Successful integration of SFL
- Significant export orders to the US
- Further acquisitions in the hearing aid space
- Small-cap liquidity risk
- Promoter selling (down 6.32%)
- Negative free cash flow
Promoters, FII and DII have decreased their holdings.
India's medical device sector is projected to grow, but geopolitical risks (Iran war, Strait of Hormuz) could disrupt supply chains and increase costs.
Acquisition of 90.69% of SFL Hearing Solutions for ₹300 million
Poor. Negative free cash flow of ₹-51.73 Cr over the last 5 years
OSEL needs to demonstrate successful integration of SFL and significant US export growth to justify its valuation. Failure to execute will lead to a sharp correction.
Primary Thesis Risk
Inability to successfully integrate SFL and capitalize on FDA approval.
For educational purposes only. Not investment advice. Consult a SEBI-registered advisor before investing.
Returns & Performance
Return on Equity (ROE)
Profit generated per ₹1 of shareholder equity
Return on Capital (ROCE)
Returns generated on total capital deployed
Oper. Profit Margin (5Y Avg)
Average operating profit margin over 5 years
Dividend Yield
Annual dividend as % of current share price
OSEL DEVICES LIMITED Valuation Check
Price to Earnings (P/E)
Share price ÷ earnings per share. Lower = cheaper
Industry Avg P/E
Average P/E of all peers in this sector
Market Capitalisation
Total market value of all outstanding shares
Growth Engine
Profit Growth (Quarterly YoY)
Net profit growth vs same quarter last year
Revenue Growth (Quarterly YoY)
Revenue growth vs same quarter last year
Revenue Growth (5-Year CAGR)
Compounded annual revenue growth over 5 years
EPS Growth (5-Year CAGR)
Earnings per share growth over 5 years
Net Profit Growth (5-Year CAGR)
Compounded annual net profit growth over 5 years
Balance Sheet Health
Debt to Equity Ratio
Total debt ÷ equity. Below 0.5 = financially healthy
Interest Coverage Ratio
EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably
Free Cash Flow (5-Year Total)
Cash left after capex over 5 years. Positive = self-funded growth
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
OSEL DEVICES LIMITED Fundamental Analysis & Valuation Benchmarking
Educational evaluation of OSELDEVICE across key market metrics for learning purposes.
Positive Indicators
10 factors identified
Strong Return on Equity (19.56%)
Observation: Efficient use of shareholders' capital generating superior returns.
Analysis: ROE >15% indicates strong profitability and effective management. This metric suggests the company can generate substantial returns on invested capital.
Excellent ROCE Performance (24.40%)
Observation: Superior returns on capital employed across business operations.
Analysis: ROCE >15% demonstrates efficient capital deployment and strong operational performance.
Strong Operating Margins (16.11%)
Observation: Healthy 5-year operating margins indicate pricing power and cost control.
Analysis: OPM >15% suggests operational efficiency and competitive advantages.
Attractive Valuation (P/E: 26.76 vs Industry: 36.70)
Observation: Trading at discount to industry peers.
Analysis: P/E below industry average may present value opportunity.
Strong Revenue Growth (47.10%)
Observation: Healthy sales growth indicates market demand and execution capability.
Analysis: Revenue growth >15% suggests strong market position and growth potential.
Consistent Growth Track Record (38.54% CAGR)
Observation: Strong 5-year sales compound annual growth rate.
Analysis: Consistent sales CAGR >12% demonstrates sustainable growth model.
Strong Profit Growth Track Record (84.72% CAGR)
Observation: Consistent 5-year profit compound annual growth rate.
Analysis: Profit CAGR >15% demonstrates scalable business model.
Strong Interest Coverage (5.54x)
Observation: Earnings comfortably cover interest obligations.
Analysis: Interest coverage >5x indicates low financial distress risk.
Balanced Promoter Holding (65.21%)
Observation: Optimal balance between promoter control and public float.
Analysis: Promoter holding in 50-75% range provides management alignment.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral.
Analysis: Absence of share pledging eliminates potential forced-selling pressure.
Risk Factors
3 factors identified
Negative Free Cash Flow (₹-81.18 Cr over 5Y)
Observation: Cash outflows exceed inflows.
Analysis: Negative FCF requires analysis of capital expenditure cycle.
Limited Institutional Interest (FII+DII: 3.74%)
Observation: Low institutional participation may affect liquidity.
Analysis: Limited institutional interest may indicate size constraints or visibility issues.
No Dividend Distribution
Observation: Company does not currently pay dividends to shareholders.
Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.
OSEL DEVICES LIMITED vs Medical Equipment & Supplies Peers
Peer Comparison - Medical Equipment & Supplies
Compare OSEL DEVICES LIMITED with 10 other companies in the same sector
| Company Info | Fundamental | Valuation | Profitability | Financial Health | Growth | Dividend | ||||
|---|---|---|---|---|---|---|---|---|---|---|
Company Company name | Score Bull Run comprehensive fundamental score based on 20+ metrics | Price Current trading price of the stock | Market Cap Total value of all shares in the market | P/E Price per share divided by earnings per share | ROE Net income divided by shareholder equity | ROCE Earnings before interest and tax divided by capital employed | Debt/Eq Total debt divided by total equity | Profit 5Y Average annual profit growth over 5 years | Sales 5Y Average annual sales growth over 5 years | Dividend Annual dividend per share divided by price per share |
OSEL DEVICES LIMITEDOSEL DEVICES LI...Selected✓ OSELDEVICE • | 67.9/100 | ₹413.05₹413 | ₹782.87₹782.87 | 26.76Average 26.8 Average | 19.56%Good 19.56% Good | 24.40%Excellent 24.40% Excellent | 0.49Excellent 0.5 Excellent | 84.72%Excellent 84.72% Excellent | 38.54%Excellent 38.54% Excellent | 0.00% |
Poly Medicure LtdPoly Medicure L... POLYMED • 531768 | 55.6/100 | ₹1702.00₹1702 | ₹17395.50₹17395.50 | 53.16Average 53.2 Average | 11.15%Average 11.15% Average | 14.04%Average 14.04% Average | 0.11Excellent 0.1 Excellent | 19.35%Excellent 19.35% Excellent | 19.02%Excellent 19.02% Excellent | 0.20% |
Fischer Medical Ventures LtdFischer Medical... FISCHER • 524743 | 21.9/100 | ₹39.13₹39 | ₹2522.43₹2522.43 | 81.32Average 81.3 Average | 8.59%Poor 8.59% Poor | 11.43%Average 11.43% Average | 0.28Excellent 0.3 Excellent | — — | — — | 0.01% |
Tarsons Products LtdTarsons Product... TARSONS • 543399 | 17.1/100 | ₹314.60₹315 | ₹1588.16₹1588.16 | 105.46Average 105.5 Average | 2.38%Poor 2.38% Poor | 4.56%Poor 4.56% Poor | 0.62Good 0.6 Good | -26.20%Poor -26.20% Poor | 13.04%Good 13.04% Good | 0.00% |
Laxmi Dental LtdLaxmi Dental Lt... LAXMIDENTL • 544339 | 69.6/100 | ₹212.69₹213 | ₹1227.22₹1227.22 | 36.70Average 36.7 Average | 14.80%Average 14.80% Average | 14.86%Average 14.86% Average | 0.05Excellent 0.1 Excellent | 103.10%Excellent 103.10% Excellent | 24.69%Excellent 24.69% Excellent | 0.00% |
HSIL LimitedHSIL Limited... HSIL • 543916 | 64.4/100 | ₹376.20₹376 | ₹547.99₹547.99 | 30.06Average 30.1 Average | 18.19%Good 18.19% Good | 19.64%Good 19.64% Good | 0.36Excellent 0.4 Excellent | 68.05%Excellent 68.05% Excellent | 31.02%Excellent 31.02% Excellent | 0.00% |
Prevest Denpro LtdPrevest Denpro ... PREVEST • 543363 | 61.5/100 | ₹401.65₹402 | ₹465.72₹465.72 | 21.74Average 21.7 Average | 18.51%Good 18.51% Good | 24.67%Excellent 24.67% Excellent | 0.00Excellent 0.0 Excellent | 24.33%Excellent 24.33% Excellent | 20.33%Excellent 20.33% Excellent | 0.26% |
38.2/100 | ₹147.10₹147 | ₹285.51₹285.51 | 56.65Average 56.6 Average | 7.54%Poor 7.54% Poor | 12.64%Average 12.64% Average | 0.10Excellent 0.1 Excellent | 42.43%Excellent 42.43% Excellent | 16.12%Excellent 16.12% Excellent | 0.00% | |
Nureca LtdNureca Ltd... NURECA • 543264 | 16.5/100 | ₹343.60₹344 | ₹260.07₹260.07 | 123.84Average 123.8 Average | 1.12%Poor 1.12% Poor | 3.30%Poor 3.30% Poor | 0.01Excellent 0.0 Excellent | -46.15%Poor -46.15% Poor | -7.19%Poor -7.19% Poor | 0.00% |
20.7/100 | ₹110.60₹111 | ₹216.85₹216.85 | 21.41Average 21.4 Average | 10.45%Average 10.45% Average | 13.18%Average 13.18% Average | 0.65Good 0.7 Good | — — | — — | 0.45% | |
32.1/100 | ₹193.50₹194 | ₹215.42₹215.42 | 23.96Average 24.0 Average | 11.99%Average 11.99% Average | 15.14%Good 15.14% Good | 0.03Excellent 0.0 Excellent | — — | — — | 0.00% | |
Top Medical Equipment & Supplies Stocks
View all →By Bull Run Score
By Return on Equity
By Market Cap
- Poly Medicure Ltd share price17395.50 Cr
- Fischer Medical Ventures Ltd share price2522.43 Cr
- Tarsons Products Ltd share price1588.16 Cr
- Laxmi Dental Ltd share price1227.22 Cr
- HSIL Limited share price547.99 Cr
OSEL DEVICES LIMITED Quarterly Performance
Latest quarterly metrics for OSELDEVICE — revenue growth and profit growth vs same quarter last year
Revenue Growth (YoY)
47.10%
Latest quarter vs same quarter previous year
Net Profit Growth (YoY)
16.78%
Latest quarter net profit vs same quarter previous year
5-Year Revenue CAGR
38.54%
Compounded annual revenue growth over 5 years
5-Year Profit CAGR
84.72%
Compounded annual net profit growth over 5 years
OSEL DEVICES LIMITED Technical Indicators
SMA 50, SMA 200, RSI and volume signals for OSELDEVICE — calculated from daily price history
Selling pressure is heavy — potential reversal zone.
Technical indicators are for educational purposes only. Not investment advice.
OSEL DEVICES LIMITED Financial Statements
Annual income statement, balance sheet and cash flow for OSEL DEVICES LIMITED (OSELDEVICE) — sourced from NSE/BSE filings.
Loading Financial Statements...
Fetching financial data for OSEL DEVICES LIMITED
About OSELDEVICE (OSEL DEVICES LIMITED)
OSEL DEVICES LIMITED (OSELDEVICE) is listed on the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE) of India. The company operates in the Medical Equipment & Supplies ...sector with a current market capitalisation of ₹782.87 (Cr). OSEL DEVICES LIMITED has delivered a Return on Equity (ROE) of 19.56% and a ROCE of 24.40%. The debt-to-equity ratio stands at 0.49, reflecting the company's capital structure. Investors tracking OSELDEVICE share price can monitor key metrics including P/E ratio, promoter holding of 65.21%, and quarterly earnings growth.
Company Details
OSELDEVICE Share Price: Frequently Asked Questions
What is the current share price of OSEL DEVICES LIMITED?
OSEL DEVICES LIMITED (OSELDEVICE) trades at ₹413.05 on NSE. Market cap ₹782.87 (Cr). Educational data only.
What is the P/E ratio of OSEL DEVICES LIMITED?
OSEL DEVICES LIMITED has a P/E of 26.76x vs industry average 36.70x.
What is the Bull Run score for OSEL DEVICES LIMITED?
OSEL DEVICES LIMITED has a Bull Run score of 67.9/100 based on 25+ financial parameters.
Does OSEL DEVICES LIMITED pay dividends?
OSEL DEVICES LIMITED has a dividend yield of 0.00%. Past dividends don't guarantee future payments.
What is the ROE of OSEL DEVICES LIMITED?
OSEL DEVICES LIMITED has ROE of 19.56%. Higher ROE indicates better use of shareholder equity.
What is the debt-to-equity ratio of OSEL DEVICES LIMITED?
OSEL DEVICES LIMITED has debt-to-equity of 0.49.
Is OSEL DEVICES LIMITED a good investment?
Bull Run gives OSEL DEVICES LIMITED a score of 67.9/100. This is not investment advice — consult a SEBI-registered advisor.